AHCYL1 anticorps (AA 31-260)

N° du produit ABIN7168521

L’anticorps Lapin Polyclonal anti-AHCYL1 a été validé pour WB, IHC et ELISA. Il convient pour détecter AHCYL1 dans des échantillons de Humain.

Aperçu rapide pour AHCYL1 anticorps (AA 31-260) (ABIN7168521)

Antigène: AHCYL1 (Adenosylhomocysteinase-Like 1 (AHCYL1))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp AHCYL1 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC), ELISA

Détail du produit anti-AHCYL1 anticorps

Épitope: AA 31-260

Fonction: AHCYL1 Antibody

Purification: Antigen Affinity Purified

Immunogène: Recombinant Human S-adenosylhomocysteine hydrolase-like protein 1 protein (31-260AA)

Isotype: IgG

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur AHCYL1

Antigène: AHCYL1 (Adenosylhomocysteinase-Like 1 (AHCYL1))

Autre désignation: AHCYL1

Sujet:

Background: Multifaceted cellular regulator which coordinates several essential cellular functions including regulation of epithelial HCO3- and fluid secretion, mRNA processing and DNA replication. Regulates ITPR1 sensitivity to inositol 1,4,5-trisphosphate competing for the common binding site and acting as endogenous \\\'pseudoligand\\\' whose inhibitory activity can be modulated by its phosphorylation status. In the pancreatic and salivary ducts, at resting state, attenuates inositol 1,4,5-trisphosphate-induced calcium release by interacting with ITPR1 (PubMed:16793548). When extracellular stimuli induce ITPR1 phosphorylation or inositol 1,4,5-trisphosphate production, dissociates of ITPR1 to interact with CFTR and SLC26A6 mediating their synergistic activation by calcium and cAMP that stimulates the epithelial secretion of electrolytes and fluid (By similarity). Also activates basolateral SLC4A4 isoform 1 to coordinate fluid and HCO3- secretion (PubMed:16769890). Inhibits the effect of STK39 on SLC4A4 and CFTR by recruiting PP1 phosphatase which activates SLC4A4, SLC26A6 and CFTR through dephosphorylation (By similarity). Mediates the induction of SLC9A3 surface expression produced by Angiotensin-2 (PubMed:20584908). Depending on the cell type, activates SLC9A3 in response to calcium or reverses SLC9A3R2-dependent calcium inhibition (PubMed:18829453). May modulate the polyadenylation state of specific mRNAs, both by controlling the subcellular location of FIP1L1 and by inhibiting PAPOLA activity, in response to a stimulus that alters its phosphorylation state (PubMed:19224921). Acts as a (dATP)-dependent inhibitor of ribonucleotide reductase large subunit RRM1, controlling the endogenous dNTP pool and ensuring normal cell cycle progression .

Aliases: AA409031 antibody, AdoHcyase 2 antibody, Ahcy-rs3 antibody, AHCYL1 antibody, DC expressed AHCY like molecule antibody, DC-expressed AHCY-like molecule antibody, DCAL antibody, Dendritic cell expressed AHCY like protein antibody, Inositol 1,4,5-trisphosphate receptor-binding protein antibody, IP3R binding protein released with inositol 1,4,5-trisphosphate antibody, IRBIT antibody, PRO0233 antibody, Putative adenosylhomocysteinase 2 antibody, S adenosyl L homocysteine hydrolase 2 antibody, S adenosylhomocysteine hydrolase like 1 antibody, S-adenosyl-L-homocysteine hydrolase 2 antibody, S-adenosylhomocysteine hydrolase-like protein 1 antibody, SAHH2_HUMAN antibody, XPVKONA antibody

UniProt: O43865